Patricia Gaule, PhD, BSc
Associate Research Scientist
Research & Publications
Biography
Coauthors
Selected Publications
- BreastMark: an integrated approach to mining publicly available transcriptomic datasets relating to breast cancer outcome.Madden SF, Clarke C, Gaule P, Aherne ST, O'Donovan N, Clynes M, Crown J, Gallagher WM. BreastMark: an integrated approach to mining publicly available transcriptomic datasets relating to breast cancer outcome. Breast Cancer Research : BCR 2013, 15:R52.
- cMET in triple-negative breast cancer: is it a therapeutic target for this subset of breast cancer patients?Gaule PB, Crown J, O'Donovan N, Duffy MJ. cMET in triple-negative breast cancer: is it a therapeutic target for this subset of breast cancer patients? Expert Opinion On Therapeutic Targets 2014, 18:999-1009.
- A Quantitative Comparison of Antibodies to Programmed Cell Death 1 Ligand 1.Gaule P, Smithy JW, Toki M, Rehman J, Patell-Socha F, Cougot D, Collin P, Morrill P, Neumeister V, Rimm DL. A Quantitative Comparison of Antibodies to Programmed Cell Death 1 Ligand 1. JAMA Oncology 2017, 3:256-259.
- Differential Expression and Significance of PD-L1, IDO-1, and B7-H4 in Human Lung Cancer.Schalper KA, Carvajal-Hausdorf D, McLaughlin J, Altan M, Velcheti V, Gaule P, Sanmamed MF, Chen L, Herbst RS, Rimm DL. Differential Expression and Significance of PD-L1, IDO-1, and B7-H4 in Human Lung Cancer. Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research 2017, 23:370-378.
- Nuclear IRF-1 expression as a mechanism to assess "Capability" to express PD-L1 and response to PD-1 therapy in metastatic melanoma.Smithy JW, Moore LM, Pelekanou V, Rehman J, Gaule P, Wong PF, Neumeister VM, Sznol M, Kluger HM, Rimm DL. Nuclear IRF-1 expression as a mechanism to assess "Capability" to express PD-L1 and response to PD-1 therapy in metastatic melanoma. Journal For Immunotherapy Of Cancer 2017, 5:25.
- B7-H3 Expression in NSCLC and Its Association with B7-H4, PD-L1 and Tumor-Infiltrating Lymphocytes.Altan M, Pelekanou V, Schalper KA, Toki M, Gaule P, Syrigos K, Herbst RS, Rimm DL. B7-H3 Expression in NSCLC and Its Association with B7-H4, PD-L1 and Tumor-Infiltrating Lymphocytes. Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research 2017, 23:5202-5209.